Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2010-11-12
pubmed:abstractText
The malignancy of tumor cells can be attenuated by interfering with cell death pathways. Since hyperthermia (HT) is a very potent radiosensitizer, the influence of HT (41.5 °C for 1 hour) alone and in combination with ionising irradiation (X-ray; 5 Gy or 10 Gy) on the form of cell death as well as on the expression of proteins known to be major components in tumor cells' apoptotic and necrotic pathways were examined in colorectal tumor cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1439-099X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
186
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
587-99
pubmed:meshHeading
pubmed-meshheading:21069267-Apoptosis, pubmed-meshheading:21069267-Apoptosis Regulatory Proteins, pubmed-meshheading:21069267-Blotting, Western, pubmed-meshheading:21069267-Caspase 3, pubmed-meshheading:21069267-Caspase 7, pubmed-meshheading:21069267-Cell Death, pubmed-meshheading:21069267-Colorectal Neoplasms, pubmed-meshheading:21069267-Combined Modality Therapy, pubmed-meshheading:21069267-Dose-Response Relationship, Radiation, pubmed-meshheading:21069267-Enzyme Activation, pubmed-meshheading:21069267-Humans, pubmed-meshheading:21069267-Hyperthermia, Induced, pubmed-meshheading:21069267-Necrosis, pubmed-meshheading:21069267-Neoplastic Stem Cells, pubmed-meshheading:21069267-Proto-Oncogene Proteins, pubmed-meshheading:21069267-Proto-Oncogene Proteins c-bcl-6, pubmed-meshheading:21069267-Tumor Cells, Cultured, pubmed-meshheading:21069267-Tumor Suppressor Protein p53, pubmed-meshheading:21069267-bcl-2-Associated X Protein
pubmed:year
2010
pubmed:articleTitle
Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells.
pubmed:affiliation
Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't